Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1983

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Oral contraception: selection and management.

AUTHORS

Bartosch JC

SOURCE

Nurse Practitioner. 1983 May;8(5):56-63, 79.

ABSTRACT

Suggestions to assist practitioners in the selection and management of oral contraceptives (OCs) for their patients

are provided. The side effects and complications attributed either to an excess of estrogen or progestogen or a

deficiency of estrogen or progestogen are summarized in tabular form. Amother table displays OCs by brand name,

according to frequency of prescription and by type amount of estrogen and progestogen contained in each brand.

The estrogen dominance rank of each brand is also provided. Before prescribing an OC, a practitioner should obtain

an OC history and perform a physical exam. Forms for recording this information are illustrated. Selection of a pill

must be based on an assessment of each patient. Pills which contain only progestogen are not as effective as

combination pills, however, these progestogen only pills should be prescribed when estrogen is contraindicated.

Since most serious side effects and complications are estrogen related, it is generally best for most patients to

begin by prescribing one of the newer sub-50 pills. The recommended pill contains .035 mcg or less of estrogen

and 1.0 mcg or less of progestogen The estrogen and progestogen content can later be modified to correct for any

side effects. Common side effects associated with the low dose pills are bleeding, nausea, and scanty menses.

Suggestions for managing these effects are provided. The pills should be discontinued if the patient complains of

1) aches or pains which might be indicative of blood clots 2) migrane headaches or headaches associated with high

blood pressure 3) severe visual problems 4) abnormal pap smears 5) breast masses and 6) any other signs which

might be associated with serious conditions. OC should not be prescribed until 2-6 weeks follwing pregnancy, but

should be prescribed as soon as possible following a miscarriage or abortion. Anticonvulsant drugs, antibiotics,

and antituberculsis drugs may interfere with the effectiveness of OCs. The new biphasic and triphasic pills are

discussed and a chart compares the levels of progestogen and estogen over the 21 day cycle for a triphasic, a

biphasic, and a sub-50 combination pill. (PubHealth.info Document ID: CONT5T 2067-06)

PubHealth.info NOTE: The author(s) of this article titled, "Oral contraception: selection and management.", is(are)

Bartosch JC. The source of this article is "Nurse Practitioner. 1983 May;8(5):56-63, 79.". This article was published

in 1983 in English language(s). (PubHealth.info® Document ID: CONT5T 2067-06. All rights reserved with

PubHealth.info) PIN: 22067

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.